23 days ago
ANGO
AnalystsWilliam PlovanicWilliam Plovanic's Stock Forecasts
AnalystsWilliam Plovanic
Analyst Ranking
Top 11%
#548 out of 5077 analysts
Average Return
+9.43%
Win Rate
52%81 out of 156
Risk vs Reward
Poor
Good
William Plovanic's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuronetics IncSTIM | +422.33% | $0.74 | $3.86 | 2024-08-13 - 2025-08-12 | Strong Buy |
Transmedics Group IncTMDX | +243.26% | $22.17 | $76.10 | 2022-03-17 - 2023-03-16 | Strong Buy |
Irhythm Technologies IncIRTC | +139.28% | $72.69 | $173.93 | 2024-09-25 - 2025-09-24 | Strong Buy |
Bioventus IncBVS | +128.57% | $5.11 | $11.68 | 2023-12-07 - 2024-12-06 | Strong Buy |
Irhythm Technologies IncIRTC | +118.15% | $82.79 | $180.61 | 2024-12-09 - 2025-10-24 | Strong Buy |
William Plovanic Analyst Color
Get additional color on William Plovanic's coverage of popular stocks
25 days ago
BSX
a month ago
IRTC
a month ago
AORT
a month ago
PODD
a month ago
HTFL
3 months ago
PODD
3 months ago
AORT
3 months ago
IRTC
3 months ago
ANGO
3 months ago
TMDX
6 months ago
DXCM
8 months ago
STIM
8 months ago
DXCM
8 months ago
ATRC
9 months ago
CVRX
a year ago
PODD
a year ago
IRTC
a year ago
CVRX
a year ago
CBLL
a year ago
BSX
a year ago
ATRC
a year ago
CBLL
a year ago
BVS
a year ago
ATRC
William Plovanic's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Boston Scientific CorpBSX | 12 | Strong Buy | $132.00 | +30.55% | Maintains | 3 days ago |
Transmedics Group IncTMDX | 7 | Strong Buy | $142.00 | +8.80% | Maintains | 12 days ago |
Angiodynamics IncANGO | 8 | Strong Buy | $18.00 | +45.87% | Maintains | 23 days ago |
Tandem Diabetes Care IncTNDM | 6 | Strong Buy | $24.00 | +60.54% | Maintains | a month ago |
Dexcom IncDXCM | 8 | Strong Buy | $106.00 | +50.72% | Maintains | a month ago |
Irhythm Technologies IncIRTC | 12 | Strong Buy | $193.00 | +6.86% | Maintains | a month ago |
Artivion IncAORT | 3 | Strong Buy | $50.00 | +15.21% | Maintains | a month ago |
Insulet CorpPODD | 5 | Strong Buy | $399.00 | +24.33% | Maintains | a month ago |
Heartflow IncHTFL | 2 | Strong Buy | $39.00 | +2.98% | Maintains | a month ago |
Neuronetics IncSTIM | 4 | Strong Buy | $7.00 | +124.36% | Maintains | 3 months ago |
Edwards Lifesciences CorpEW | 24 | Hold | $81.00 | +6.44% | Maintains | 3 months ago |
Globus Medical IncGMED | 4 | Strong Buy | $90.00 | +44.49% | Maintains | 3 months ago |
Zimmer Biomet Holdings IncZBH | 3 | Hold | $101.00 | -1.97% | Maintains | 5 months ago |
Cvrx IncCVRX | 8 | Strong Buy | $18.00 | +72.25% | Maintains | 7 months ago |
Trisalus Life Sciences IncTLSI | 4 | Strong Buy | $11.00 | +114.84% | Maintains | 7 months ago |
Atricure IncATRC | 11 | Strong Buy | $52.00 | +38.52% | Maintains | 7 months ago |
Ceribell IncCBLL | 4 | Strong Buy | $33.00 | +156.01% | Maintains | 8 months ago |
Nevro CorpNVRO | 12 | Hold | $5.85 | +0.17% | Maintains | 9 months ago |
Inari Medical IncNARI | 12 | Hold | $80.00 | +0.04% | Downgrades | 10 months ago |
Bioventus IncBVS | 4 | Strong Buy | $15.00 | +116.14% | Maintains | a year ago |
Shockwave Medical IncSWAV | 6 | Hold | $335.00 | N/A | Downgrades | 2 years ago |
Penumbra IncPEN | 4 | Strong Buy | $284.00 | N/A | Reiterates | 2 years ago |
Alphatec Holdings IncATEC | 1 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Pulmonx CorpLUNG | 4 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Merit Medical Systems IncMMSI | 4 | Hold | $70.00 | N/A | Maintains | 2 years ago |
Staar Surgical CoSTAA | 5 | Hold | $48.00 | N/A | Downgrades | 2 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Vapotherm IncVAPO | 2 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Acutus Medical IncAFIB | 4 | Hold | $3.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.